Meta-Analysis Supports Ovarian Suppression in Breast Cancer Meta-Analysis Supports Ovarian Suppression in Breast Cancer
A new meta-analysis of 25 studies provides more evidence linking ovarian suppression/ablation in premenopausal women with breast cancer to less recurrence and longer survival.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Ovarian Cancer Drug Extends Survival in Resistant Disease
(MedPage Today) -- CHICAGO -- An antibody-microtubule inhibitor conjugate improved survival in selected patients with advanced platinum-resistant ovarian cancer compared with standard chemotherapy, representing the first novel drug to do so in... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 4, 2023 Category: Hematology Source Type: news
How a £2m robot surgeon cuts recovery time for women left in agony by womb condition endometriosis
Endometriosis affects 1.5 million women in the UK and develops when tissue that would normally line the womb starts to grow in other parts of the body, such as the ovaries, bowel and bladder. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2023 Category: Consumer Health News Source Type: news
Hundreds of women could benefit from ovarian cancer drug pairing that doubles chance of remission
A new drug combination trialed by Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, was twice as effective as existing ovarian cancer treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2023 Category: Consumer Health News Source Type: news
Fresh drug combination promises to hold back the Ovarian cancer for FIVE YEARS
Around 7,500 women are diagnosed with ovarian cancer each year in the UK. As it causes few symptoms in early stages, it's picked up at a late stage in the majority of cases. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2023 Category: Consumer Health News Source Type: news
Pricey Drug Combo Boosts PFS in First-Line Advanced Ovarian Cancer
(MedPage Today) -- CHICAGO -- A three-drug combination significantly improved progression-free survival (PFS) in newly diagnosed non-BRCA advanced ovarian cancer but raised questions about the cost of the regimen, according to a study reported... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 3, 2023 Category: American Health Source Type: news
New drug combination offers ovarian cancer breakthrough
The revolutionary treatment has been shown to significantly shrink tumours in almost half of patients with the diseaseThousands of women withovarian cancer could benefit from a revolutionary drug combination after it was shown to significantly shrink tumours in almost half of patients with the disease.The new treatment blocks tumour growth, helping keep the disease at bay for years. Experts said the “fantastic” and “very exciting” results from clinical trials of the drug combination, presented at the world’s largest cancer conference this weekend, showed it was “far more effective” than any available option f...
Source: Guardian Unlimited Science - June 3, 2023 Category: Science Authors: Andrew Gregory Health editor in Chicago Tags: Cancer research Health Women's health Medical research Science Source Type: news
' Huge Step Forward' in Advanced Ovarian Cancer'Huge Step Forward' in Advanced Ovarian Cancer
Adding both durvalumab and olaparib to standard-of-care treatment in newly diagnosed non-BRCA mutated advanced ovarian cancer represents a ' huge step forward, ' says one expert.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FDA to allow imports of cancer drug from China amid ongoing shortage
The US Food and Drug Administration is working with Chinese drugmaker Qilu Pharmaceutical to import the cancer medication cisplatin to boost supply amid an ongoing shortage. Canadian pharmaceutical company Apotex will distribute the injectable medication in 50-milligram vials on a temporary basis.…#qilupharmaceutical #apotex #ovarian #gastric #fda #robertcaliff #cisplatin #amandafader #doxil (Source: Reuters: Health)
Source: Reuters: Health - June 3, 2023 Category: Consumer Health News Source Type: news
UTHSC scores DoD grant for ovarian cancer drug; U of M gets national designation for cyber defense efforts
Both the U of M and UTHSC are remaining busy in 2023, as they look to continue growing in national prominence. Here are some of the things they've been up to lately. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 2, 2023 Category: Pharmaceuticals Authors: John Klyce Source Type: news
Olaparib Gains BRCA-Mutated Prostate Cancer Indication Olaparib Gains BRCA-Mutated Prostate Cancer Indication
The new indication adds to the PARP inhibitor ' s previous approvals for HRR-mutated metastatic castration-resistant prostate cancer as well as for ovarian, breast, and pancreatic cancer indications.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - June 1, 2023 Category: Urology & Nephrology Tags: Hematology-Oncology News Alert Source Type: news
Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, May 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of an investigational single tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) for the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) in adult patients with WHO functional class (FC) II-III.[1] The application is based on positive data from the Phase 3 A DUE study, which met its primary endpoint and demonstrated that M/T STCT si...
Source: Johnson and Johnson - May 30, 2023 Category: Pharmaceuticals Source Type: news
Correlation between selected clinical symptoms and severity of aggression, impulsiveness and their selected behavioral manifestations in patients with polycystic ovary syndrome phenotype A - Barabasz-Gembczyk A, M ędrala W, Rodek P, Alli-Balogun B, Chrobak J, Cwynar M, Sikora D, Wójtowicz M, Franik G, Madej P, Kucia K.
Previous studies on aggressiveness and impulsiveness in women with polycystic ovary syndrome (PCOS) are ambiguous. Furthermore, no biochemical or clinical factors related to these variables have been definitively confirmed. The aim of the study was to clar... (Source: SafetyLit)
Source: SafetyLit - May 29, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Ovarian cancer which killed Carrie actress aged 28 can spread from stage 1 to 3 in a YEAR
Carrie actress Samantha Weinstein died aged 28 following a two-and-a-half-year battle with ovarian cancer. She realized she had ovarian cancer aged 25 after being 'strangely bloated'. (Source: the Mail online | Health)
Source: the Mail online | Health - May 25, 2023 Category: Consumer Health News Source Type: news
UK Parliament, Riddled With Asbestos, Faces Restoration Delays
Lawmakers say that Britain’s Palace of Westminster is at risk of demolition because the iconic and historic structure needs several costly repairs, including asbestos removal.
Nearly 120 workers and other people inside the palace were potentially exposed to asbestos during a 2022 renovation in the speaker’s residential space. In addition to asbestos and its cancer risks, the building is rife with leaks and is crumbling in areas.
Some are worried the entire structure, in which both houses of Parliament meet, is at risk in the event of a catastrophic incident. A report from the House of Commons Public Accounts Comm...
Source: Asbestos and Mesothelioma News - May 25, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news
